Novel biotechnological approaches for monitoring and immunization against resistant to antibiotics Escherichia coli and other pathogenic bacteria
- PMID: 33138825
- PMCID: PMC7607641
- DOI: 10.1186/s12917-020-02633-8
Novel biotechnological approaches for monitoring and immunization against resistant to antibiotics Escherichia coli and other pathogenic bacteria
Abstract
The application of next-generation molecular, biochemical and immunological methods for developing new vaccines, antimicrobial compounds, probiotics and prebiotics for zoonotic infection control has been fundamental to the understanding and preservation of the symbiotic relationship between animals and humans. With increasing rates of antibiotic use, resistant bacterial infections have become more difficult to diagnose, treat, and eradicate, thereby elevating the importance of surveillance and prevention programs. Effective surveillance relies on the availability of rapid, cost-effective methods to monitor pathogenic bacterial isolates. In this opinion article, we summarize the results of some research program initiatives for the improvement of live vaccines against avian enterotoxigenic Escherichia coli using virulence factor gene deletion and engineered vaccine vectors based on probiotics. We also describe methods for the detection of pathogenic bacterial strains in eco-environmental headspace and aerosols, as well as samples of animal and human breath, based on the composition of volatile organic compounds and fatty acid methyl esters. We explain how the introduction of these low-cost biotechnologies and protocols will provide the opportunity to enhance co-operation between networks of resistance surveillance programs and integrated routine workflows of veterinary and clinical public health microbiology laboratories.
Keywords: And FAMEs; Antibiotics; Bacterial vaccines; Microbiomes; Probiotics; VOCs.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.Microb Pathog. 2018 Apr;117:162-169. doi: 10.1016/j.micpath.2018.02.032. Epub 2018 Feb 21. Microb Pathog. 2018. PMID: 29474827 Review.
-
Effects of in ovo probiotic administration on the incidence of avian pathogenic Escherichia coli in broilers and an evaluation on its virulence and antimicrobial resistance properties.Poult Sci. 2021 Mar;100(3):100903. doi: 10.1016/j.psj.2020.11.072. Epub 2020 Dec 10. Poult Sci. 2021. PMID: 33518345 Free PMC article.
-
Implications of enterotoxigenic Escherichia coli genomics for vaccine development.Expert Rev Vaccines. 2015 Apr;14(4):551-60. doi: 10.1586/14760584.2015.996553. Epub 2014 Dec 26. Expert Rev Vaccines. 2015. PMID: 25540974 Review.
-
Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.Methods Mol Biol. 2016;1403:363-83. doi: 10.1007/978-1-4939-3387-7_19. Methods Mol Biol. 2016. PMID: 27076141 Free PMC article.
-
Preparation of porcine enterotoxigenic Escherichia coli (ETEC) ghosts and immunogenic analysis in a mouse model.Microb Pathog. 2019 Jan;126:224-230. doi: 10.1016/j.micpath.2018.11.015. Epub 2018 Nov 11. Microb Pathog. 2019. PMID: 30428380
Cited by
-
Antioxidant and Antibacterial Activities of Nano-probiotics Versus Free Probiotics Against Gastrointestinal Pathogenic Bacteria.Indian J Microbiol. 2024 Mar;64(1):141-152. doi: 10.1007/s12088-023-01140-2. Epub 2023 Nov 26. Indian J Microbiol. 2024. PMID: 38468740 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical